Nuwellis Inc (NUWE)

$1.97 -0.04 (-1.99%)
Market Cap 3.33M
Revenue (ttm) 8.74M
Net Income (ttm) -11.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -127.80%
Debt to Equity Ratio 0.00
Volume 12,200
Avg Vol 73,790
Day's Range N/A - N/A
Shares Out 1.66M
Stochastic %K 67%
Beta -0.19
Analysts Hold
Price Target $11.00

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 345 4200
Address:
12988 Valley View Road, Eden Prairie, United States
bazooka007
bazooka007 Jan. 8 at 5:28 PM
$NUWE 2 bucks extremely hard to crack. Whats the volume today? 5k! Ok i go back to bed.
0 · Reply
bazooka007
bazooka007 Jan. 7 at 7:13 PM
$NUWE please not too much price action. But hey, as soon as volume comes in, this will fly to the moon.
0 · Reply
Kyle_5
Kyle_5 Jan. 6 at 6:35 PM
$NUWE Bullet in chamber 2.06/2.07? @Love_To_Learn
1 · Reply
bazooka007
bazooka007 Jan. 6 at 5:40 PM
$NUWE patent news and a volume of 30k. Excactly my kind of humour.
0 · Reply
JohnTrack
JohnTrack Jan. 6 at 3:07 PM
$NUWE Patents win, nice move! https://www.rapidticker.com/news/nuwe-nuwellis-announces-issuance-of-new-ea6420
0 · Reply
DARKP00L
DARKP00L Jan. 6 at 1:54 PM
$NUWE 08:17 on Jan. 06 2026 Nuwellis Granted New Patent From U.S. Patent And Trademark Office For Advanced Safety Mechanisms For Blood Return Line Clamps Used In Extracorporeal Blood Filtration Systems #tradeideas
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 6 at 1:16 PM
$NUWE Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal TherapyPatent issuance strengthens pediatric intellectual property portfolio and advances system-level safety design
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 5 at 1:50 PM
$VRME ACCESSIGN OLD $NUWE ADD TO YOUR QUESTION DON @chuckld
3 · Reply
bazooka007
bazooka007 Jan. 1 at 9:19 PM
$NUWE like this and not otherwise
0 · Reply
bazooka007
bazooka007 Dec. 31 at 8:50 PM
$NUWE finishing the year @ 52 week low. What a shit show.
0 · Reply
Latest News on NUWE
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Jan 6, 2026, 8:15 AM EST - 2 days ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 9, 2025, 8:15 AM EST - 4 weeks ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Dec 4, 2025, 8:15 AM EST - 5 weeks ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 12, 2025, 10:11 AM EST - 2 months ago

Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 12, 2025, 8:15 AM EST - 2 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nov 10, 2025, 9:00 AM EST - 2 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 9:00 AM EDT - 2 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 30, 2025, 8:45 AM EDT - 3 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 18, 2025, 9:00 AM EDT - 4 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 17, 2025, 10:16 AM EDT - 4 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 4 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 4 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 5 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 5 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 5 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 2:37 PM EDT - 5 months ago

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 5 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 5 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 5 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 5 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 5 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 6 months ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 6 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 6 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 6 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Appoints John Erb as Chief Executive Officer

Jul 2, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 10, 2025, 4:15 PM EDT - 7 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Jun 9, 2025, 9:15 AM EDT - 7 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:50 AM EDT - 8 months ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025, 7:00 AM EDT - 8 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025, 7:00 AM EDT - 8 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025, 7:00 AM EDT - 8 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 24, 2025, 7:00 AM EDT - 9 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Apr 22, 2025, 4:05 PM EDT - 9 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 12:23 PM EDT - 10 months ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 10 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 24, 2025, 4:05 PM EST - 11 months ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 20, 2025, 8:00 AM EST - 11 months ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 18, 2025, 4:15 PM EST - 11 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 11:02 AM EST - 1 year ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 11, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 5, 2024, 9:28 AM EST - 1 year ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 4, 2024, 8:30 AM EST - 1 year ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nov 1, 2024, 4:15 PM EDT - 1 year ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Oct 23, 2024, 4:15 PM EDT - 1 year ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Sep 25, 2024, 4:15 PM EDT - 1 year ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 12:39 PM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

bazooka007
bazooka007 Jan. 8 at 5:28 PM
$NUWE 2 bucks extremely hard to crack. Whats the volume today? 5k! Ok i go back to bed.
0 · Reply
bazooka007
bazooka007 Jan. 7 at 7:13 PM
$NUWE please not too much price action. But hey, as soon as volume comes in, this will fly to the moon.
0 · Reply
Kyle_5
Kyle_5 Jan. 6 at 6:35 PM
$NUWE Bullet in chamber 2.06/2.07? @Love_To_Learn
1 · Reply
bazooka007
bazooka007 Jan. 6 at 5:40 PM
$NUWE patent news and a volume of 30k. Excactly my kind of humour.
0 · Reply
JohnTrack
JohnTrack Jan. 6 at 3:07 PM
$NUWE Patents win, nice move! https://www.rapidticker.com/news/nuwe-nuwellis-announces-issuance-of-new-ea6420
0 · Reply
DARKP00L
DARKP00L Jan. 6 at 1:54 PM
$NUWE 08:17 on Jan. 06 2026 Nuwellis Granted New Patent From U.S. Patent And Trademark Office For Advanced Safety Mechanisms For Blood Return Line Clamps Used In Extracorporeal Blood Filtration Systems #tradeideas
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 6 at 1:16 PM
$NUWE Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal TherapyPatent issuance strengthens pediatric intellectual property portfolio and advances system-level safety design
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 5 at 1:50 PM
$VRME ACCESSIGN OLD $NUWE ADD TO YOUR QUESTION DON @chuckld
3 · Reply
bazooka007
bazooka007 Jan. 1 at 9:19 PM
$NUWE like this and not otherwise
0 · Reply
bazooka007
bazooka007 Dec. 31 at 8:50 PM
$NUWE finishing the year @ 52 week low. What a shit show.
0 · Reply
done84
done84 Dec. 31 at 8:17 PM
$NUWE awesome performance again this year. (-96%) Well done f*ckers!🖕🖕 Hopefully next year this worthless toxic scam company will be kicked out from Nasdaq for good! OTC where this sh*t belongs and management to the hell!
1 · Reply
HodlandRelax
HodlandRelax Dec. 31 at 6:47 PM
$NUWE did this management team think changing their name would help? Still the same old CHF Solutions. Literal hot garbage
0 · Reply
done84
done84 Dec. 30 at 4:26 PM
$NUWE 😂😂
1 · Reply
bazooka007
bazooka007 Dec. 30 at 4:04 PM
$NUWE
0 · Reply
bazooka007
bazooka007 Dec. 29 at 7:44 PM
$NUWE
0 · Reply
done84
done84 Dec. 29 at 7:02 PM
$NUWE scam compamy. Delist this sh*t finally! 🖕🖕🖕
0 · Reply
done84
done84 Dec. 29 at 5:59 PM
$NUWE 👇👇 The smart ones. 😂😂🖕🖕🖕
0 · Reply
bazooka007
bazooka007 Dec. 29 at 3:09 PM
$NUWE wtf is selling this at 2 bucks? I'm asking for a friend
0 · Reply
Russell007xx
Russell007xx Dec. 29 at 12:29 PM
$NUWE don’t want to say but I feel soon it will be under 1 and then another RS
0 · Reply
InvisibleHandV3
InvisibleHandV3 Dec. 26 at 3:19 PM
$NUWE Leadership will be measured by consistency rather than by vision alone. Margin trajectory needs to confirm that scale creates leverage, not dilution. Transparency improvements could narrow valuation discounts. The trajectory strengthens as results compound visibly.
2 · Reply
Jacks10
Jacks10 Dec. 24 at 4:08 PM
$NUWE a few months ago I thought we were heading to $6, time for a sharp reversal here! Just unbelievable!
0 · Reply
done84
done84 Dec. 23 at 11:15 PM
$NUWE this worthless company has been listed on Nasdaq since 2012. Delivered absolutely nothing but endless dilution and countless reverse splits. Robbed more than enough and caused more damage to the shareholders than they think. Time to switch off the light. This whole chfs or nuwe robbery has gone too far. Happy new year to everybody except this worthless junk company and criminal management! Rot in hell f*ckers! 🖕🖕
1 · Reply